E R Froesch

Author PubWeight™ 169.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Actions of insulin-like growth factors. Annu Rev Physiol 1985 3.80
2 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 1982 2.79
3 Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 1981 2.52
4 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987 2.00
5 Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem 1978 1.88
6 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 1989 1.83
7 Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983 1.72
8 The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul 1981 1.63
9 Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 1992 1.58
10 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci U S A 1988 1.55
11 Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys 1975 1.52
12 Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology 1980 1.48
13 Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage. Proc Natl Acad Sci U S A 1976 1.45
14 Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia 1993 1.45
15 Body size parallels insulin-like growth factor I levels but not growth hormone secretory capacity. Acta Endocrinol (Copenh) 1984 1.43
16 Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism 1978 1.40
17 Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med 1983 1.38
18 Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 1986 1.37
19 Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab 1984 1.35
20 Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986 1.35
21 Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A 1989 1.33
22 Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 1979 1.32
23 Fibroblasts as an experimental tool in metabolic and hormone studies. II. Effects of insulin and nonsuppressible insulin-like activity (NSILA-S) on fibroblasts in culture. Eur J Clin Invest 1973 1.29
24 Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest 1979 1.28
25 Non-suppressible insulin-like activity of human serum. I. Physicochemical properties, extraction and partial purification. Biochim Biophys Acta 1966 1.20
26 Insulin-like growth factors and insulin: comparative aspects. Diabetologia 1985 1.20
27 Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor. Eur J Biochem 1981 1.18
28 Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh) 1985 1.16
29 Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 1992 1.15
30 Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I. N Engl J Med 1981 1.13
31 Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs. Acta Endocrinol (Copenh) 1976 1.12
32 The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. J Biol Chem 1975 1.11
33 Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci U S A 1988 1.11
34 Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 1983 1.10
35 Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest 1990 1.09
36 Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites. Biochem Biophys Res Commun 1974 1.09
37 Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh) 1980 1.09
38 Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982 1.08
39 Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA. J Clin Invest 1968 1.07
40 Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest 1992 1.04
41 Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? J Clin Endocrinol Metab 1982 1.03
42 NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. Diabetologia 1978 1.03
43 Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci U S A 1990 1.03
44 Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF I and IGF II) in primary cultures of chicken embryonic cells. FEBS Lett 1983 1.03
45 Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 1991 1.00
46 Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 1991 0.99
47 Nonsuppressible insulinlike activity of human serum: purification, physiochemical and biological properties and its relation to total serum ILA. Recent Prog Horm Res 1967 0.99
48 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci U S A 1989 0.99
49 Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest 1986 0.98
50 Specific binding of nonsupressible insulinlike activity to chicken embryo fibroblasts and to a solubilized fibroblast receptor. Arch Biochem Biophys 1975 0.97
51 Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci U S A 1994 0.97
52 Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993 0.97
53 Effects of partially purified preparations with nonsuppressible insulin-like activity (NSILA-S) on sulfate incorporation into rat and chicken cartilage. Diabetologia 1973 0.96
54 Effect of insulin-like growth factor on collagen and glycosaminoglycan synthesis by rabbit articular chondrocytes in culture. Experientia 1982 0.95
55 Letter: Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet 1973 0.95
56 Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Commun 1988 0.94
57 Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology 1993 0.94
58 Inhibition of phosphorylase-a by fructose-1-phosphate, alpha-glycerophosphate and fructose-1,6-diphosphate: explanation for fructose-induced hypoglycaemia in hereditary fructose intolerance and fructose-1,6-diphosphatase deficiency. Eur J Clin Invest 1973 0.94
59 Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci U S A 1988 0.93
60 Biological properties of NSILA-S. Adv Metab Disord 1975 0.92
61 Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 1989 0.92
62 Effects of insulin and NSILA on adipocytes of normal and diabetic rats: receptor binding, glucose transport and glucose metabolism. Diabetologia 1977 0.92
63 Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats. Acta Endocrinol (Copenh) 1978 0.91
64 Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A. Eur J Endocrinol 1994 0.91
65 Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man. J Intern Med 1997 0.91
66 Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. J Clin Endocrinol Metab 1977 0.91
67 Disorders of fructose metabolism. Clin Endocrinol Metab 1976 0.91
68 Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity. Biochim Biophys Acta 1966 0.91
69 Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay. Clin Chem 1977 0.91
70 The pathogenesis of tumour hypoglycaemia: blocks of hepatic glucose release and of adipose tissue lipolysis. Diabetologia 1967 0.91
71 Increased sensitivity of rat adipose tissue to the lipolytic action of epinephrine during fasting and its reversal during re-feeding. FEBS Lett 1977 0.90
72 Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart. Biochem Biophys Res Commun 1977 0.90
73 Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Copenh) 1983 0.90
74 Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells. FEBS Lett 1984 0.90
75 Hereditary fructose intolerance. Dental status of eight patients. Br Dent J 1967 0.90
76 Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology 1994 0.90
77 Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol 1990 0.89
78 Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab 1998 0.89
79 Treatment with insulin-like growth factor I alters capillary permeability in skin and retina. Diabetes 1995 0.89
80 Pathophysiological and clinical aspects of the insulin-like growth factors. Horm Res 1986 0.89
81 Familial Cushing's syndrome with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). Acta Endocrinol (Copenh) 1980 0.89
82 Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res 1986 0.89
83 Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats. Diabetologia 1979 0.88
84 Insulin-like growth factors stimulate synthesis of nucleic acids and glycogen in cultured calvaria cells. Calcif Tissue Int 1983 0.88
85 Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 1994 0.87
86 Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem Biophys Res Commun 1991 0.87
87 Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from the small molecular weight forms. FEBS Lett 1978 0.87
88 Effects of insulin on glucose metabolism and glucose transport in fat cells of hormone-treated hypophysectomized rats: evidence that growth hormone restricts glucose transport. Endocrinology 1979 0.86
89 Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia. J Biol Chem 1990 0.86
90 Effect of glucose on spontaneous limitation of lipolysis in isolated adipose tissue: a potential regulatory mechanism. Ann N Y Acad Sci 1965 0.86
91 Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 1998 0.85
92 Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I. Biochem Biophys Res Commun 1996 0.85
93 Immunoreactive insulin, suppressible, and non suppressible insulinlike activities in rats after administration of glucose and induction of hyperglycaemia by mannoheptulose. Diabetologia 1966 0.85
94 Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur J Endocrinol 1997 0.85
95 Metabolic state, pancreatic insulin content and B-cell morphology of normoglycemie spiny mice (Acomys cahirinus): indications for an impairment of insulin secretion. Diabetologia 1970 0.85
96 Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors. Biochem Biophys Res Commun 1988 0.84
97 Fibroblasts as an experimental tool in metabolic and hormone studies. I. Growth and glucose metabolism of fibroblasts in culture. Eur J Clin Invest 1973 0.84
98 The pharmacokinetics of free insulin-like growth factor-I in healthy subjects. Growth Horm IGF Res 1999 0.84
99 The physiology and pharmacology of adipose tissue lipolysis: its inhibition and implications for the treatment of diabetes. Diabetologia 1967 0.84
100 Effect of insulin on glucose transport and metabolism in adipose tissue and skeletal muscle of hypophysectomized rats. FEBS Lett 1981 0.84
101 Nonsuppressible insulin-like activity (NSILA) of human serum. V. Hypoglycaemia and preferential metabolic stimulation of muscle by NSILA-S. Eur J Clin Invest 1970 0.84
102 Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozotocin-diabetic rats. FEBS Lett 1989 0.83
103 Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation. Acta Endocrinol (Copenh) 1984 0.83
104 Parathormone promotes glycogen formation from [14C]glucose in cultured osteoblast-like cells. FEBS Lett 1982 0.83
105 Effects of insulin-like growth factors on chick embryo hepatocytes. Acta Endocrinol (Copenh) 1985 0.83
106 Transport and metabolism of fructose in fat cells of normal and hypophysectomized rats. Am J Physiol 1979 0.82
107 Inhibition of insulin degradation by insulin-like growth factors I and II in human hepatoma (HepG2) cells. Acta Endocrinol (Copenh) 1989 0.82
108 Increase in milk secretion and mammary blood flow by intra-arterial infusion of insulin-like growth factor-I into the mammary gland of the goat. J Endocrinol 1990 0.82
109 Insulin-like growth factor in pregnancy: studies in a growth hormone-deficient dwarf. J Clin Endocrinol Metab 1982 0.82
110 Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat. Eur J Endocrinol 1998 0.82
111 Fructose metabolism in adipose tissue. Acta Med Scand Suppl 1972 0.81
112 Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun 1989 0.81
113 Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 1995 0.81
114 Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblastic cells. Prog Growth Factor Res 1995 0.81
115 Is increased basal lipolysis in adipose tissue of fasted-refed rats related to cyclic-AMP-dependent mechanisms? Eur J Biochem 1981 0.81
116 Increased sensitivity to lipolytic hormones of adenylate cyclase in fat cells of diabetic rats. Eur J Biochem 1980 0.81
117 Binding of insulin and nonsuppressible insulin-like activity to isolated perfused rat heart muscle. Evidence for two separate binding sites. Arch Biochem Biophys 1976 0.81
118 In vivo effects of the insulin-like growth factors (IGFs) in the hypophysectomized rat: comparison with human growth hormone and the possible role of the specific IGF carrier proteins. Ciba Found Symp 1985 0.80
119 Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures. Am J Physiol 1996 0.80
120 [Comparative studies on the metabolism of xylitol, sorbitol, and fructose in humans]. Schweiz Med Wochenschr 1972 0.80
121 Production of carrier proteins for insulin-like growth factors (IGFs) by rat osteoblastic cells. Regulation by IGF I and cortisol. FEBS Lett 1989 0.80
122 Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Eur J Endocrinol 1996 0.80
123 Insulin-like growth factors in the Göttinger miniature-pig. Acta Endocrinol (Copenh) 1988 0.80
124 Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. J Steroid Biochem 1989 0.80
125 Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats. Eur J Endocrinol 1994 0.80
126 46,XX/46,XY chimerism in a phenotypically normal man. Hum Genet 1983 0.80
127 Functional properties of a heterozygous mutation (Arg1174-->Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient. FEBS Lett 1994 0.80
128 Regulation of rat adipocyte glucose transport by growth hormone: no mediation by insulin-like growth factors. Endocrinology 1983 0.80
129 Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels. Diabetologia 1982 0.80
130 The role of insulin-like growth factor I in growth of diabetic rats. Acta Endocrinol (Copenh) 1989 0.79
131 Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J Clin Endocrinol Metab 1996 0.79
132 IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates. Am J Physiol 1997 0.79
133 Osteoblastlike cells in a serum-free methylcellulose medium form colonies: effects of insulin and insulinlike growth factor I. Calcif Tissue Int 1987 0.79
134 Binding of nonsuppressible insulin-like activity (NSILA) to isolated fat cells: evidence for two separate membrane acceptor sites. FEBS Lett 1976 0.79
135 Triiodothyronine stimulates proliferation of osteoblast-like cells in serum-free culture. FEBS Lett 1987 0.79
136 Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro. FEBS Lett 1992 0.79
137 Increased sensitivity of diabetic rat adipose tissue towards the lipolytic action of epinephrine. Diabetologia 1975 0.79
138 Insulin hypoglycaemia in normal and adrenalectomized subjects: comparison of metabolic parameters and endocrine counter regulation. Acta Endocrinol (Copenh) 1981 0.79
139 Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus. Diabetes 1984 0.79
140 Effects of hormones on cyclic AMP release from rat adipose tissue in vitro. FEBS Lett 1974 0.79
141 A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 1996 0.79
142 Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas? Lancet 1982 0.78
143 Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. N Engl J Med 1982 0.78
144 Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline. Am J Physiol 1997 0.78
145 Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. Endocrinology 1989 0.78
146 Eleven cases of hereditary fructose intolerance in one Swiss family with a pair of monozygotic and of dizygotic twins. Helv Paediatr Acta 1981 0.78
147 Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy. Acta Endocrinol (Copenh) 1977 0.78
148 Effects of insulin-like growth factor I in man. Acta Paediatr Scand Suppl 1990 0.78
149 Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. I. Inhibition of lipolysis, effects on glucose, fructose, and glycogen metabolism in vitro and comparison with insulin. Mol Pharmacol 1967 0.78
150 Prostaglandin E2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitro. J Bone Miner Res 1992 0.77
151 Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. II. Antilipolytic and hypoglycemic effects in vivo. Mol Pharmacol 1967 0.77
152 1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts. FEBS Lett 1996 0.77
153 Polar surface distribution of type II insulin-like growth factor receptor in rat hepatocytes. Mol Cell Endocrinol 1990 0.77
154 Glucose transport in adipocytes and its control by growth hormone in vivo. Am J Physiol 1982 0.77
155 In vivo control of the insulin-suppressible high-affinity Ca2+-ATPase of fat cell membranes by growth hormone and its possible involvement in the regulation of glucose transport. FEBS Lett 1981 0.77
156 Insulin inhibition of spontaneous adipose tissue lipolysis and effects upon fructose and glucose metabolism. Mol Pharmacol 1965 0.77
157 Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am J Physiol 1994 0.77
158 In vivo control of insulin-sensitive phosphodiesterase in rat adipocytes by growth hormone and its parallelism to glucose transport. Endocrinology 1981 0.77
159 Insulin-like growth factor I and cardiac performance in heart failure. Growth Horm IGF Res 1998 0.77
160 Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity. Metabolism 1995 0.77
161 Increased sensitivity to epinephrine of the cyclic AMP--protein kinase system in adipose tissue of diabetic rats. FEBS Lett 1978 0.77
162 Treatment of type A insulin resistance with insulin-like growth factor-I. Lancet 1993 0.77
163 Insulin-like growth factors (IGFs) in pygmies and subjects with the pygmy trait: characterization of the metabolic actions of IGF I and IGF II in man. J Clin Endocrinol Metab 1982 0.77
164 Glucose uptake and phosphorylation in fat cells of fasted and hypophysectomized rats. Mol Cell Endocrinol 1986 0.77
165 Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol (Copenh) 1992 0.76
166 Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum. Biochem Biophys Res Commun 1993 0.76
167 Insulin-like growth factor-I lowers fasting and postprandial triglyceride levels without affecting chylomicron clearance in healthy men. J Intern Med 1999 0.76
168 Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations. Acta Endocrinol (Copenh) 1987 0.76
169 In-frame exon 2 deletion in insulin receptor RNA in a family with extreme insulin resistance in association with defective insulin binding: a case report. Eur J Endocrinol 1996 0.76
170 Production of IGFBP-3 by connective tissue and endothelial cells. Growth Regul 1993 0.76
171 Glucose turnover and insulin secretion in dogs with pancreatic allografts. Diabetologia 1970 0.76
172 Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Lett 1993 0.76
173 Growth hormone and serum leptin in GH-deficient adults. Clin Endocrinol (Oxf) 1997 0.75
174 Triiodothyronine increases responsiveness of cultured rat bone cells to parathyroid hormone. Acta Endocrinol (Copenh) 1986 0.75
175 Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH-deficient adults. Diabetologia 1997 0.75
176 [Control of the juvenile diabetic with the insulin dosage device: indications and uses]. Schweiz Med Wochenschr 1981 0.75
177 Effects of subcutaneous insulin-like growth factor-I infusion on skin microcirculation. Int J Microcirc Clin Exp 1995 0.75
178 Mechanism of the antilipolytic action of NSILA-S: inhibition of adenylate cyclase activity in lipocyte ghosts. Horm Metab Res 1973 0.75
179 Spontaneous postoperative normalization of growth hormone levels in two patients with acromegaly not cured by transsphenoidal surgery. Neurosurgery 1988 0.75
180 [New studies on the nature of the non-suppressible insulin-like activity (NSILA) of human serum]. Schweiz Med Wochenschr 1970 0.75
181 [IGFs/somatomedins: physiological and physiopathological significance]. Journ Annu Diabetol Hotel Dieu 1985 0.75
182 Clinical and metabolic aspects of fructose. Concluding remarks. Acta Med Scand Suppl 1972 0.75
183 Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem Biophys Res Commun 1995 0.75
184 Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts. Diabetes Care 1981 0.75
185 [No dental caries in individuals with hereditary fructose intolerance]. Helv Med Acta 1967 0.75
186 [A new, simple and very informative method of blood lipid determination with the Stone and Thorp nephelometer]. Schweiz Med Wochenschr 1968 0.75
187 [The therapy of diabetic coma: quantitative value of insulin loss on the infusion instruments]. Schweiz Med Wochenschr 1975 0.75
188 IGF-I alters skeletal muscle substrate metabolism and blunts recovery from insulin-induced hypoglycemia. Am J Physiol 1996 0.75
189 [Parenteral feeding: glucose or glucose substitutes?]. Schweiz Med Wochenschr 1978 0.75
190 [A patient with 46 XX/46 XY chimerism without hermaphroditism. The problem of prepuberal diagnosis of the Klinefelter's syndrome]. Schweiz Med Wochenschr 1983 0.75
191 Growth hormone and insulin-like growth factor I in German shepherd dwarf dogs. Acta Endocrinol (Copenh) 1984 0.75
192 Lipase activity in the fat cake and aqueous phase of adipose tissue homogenate of fed, fasted and fasted-refed rats. Eur J Clin Invest 1970 0.75
193 Microalbuminuria and nerve conduction velocity in type-I diabetics during conventional therapy and during continuous i.v. insulin infusion. Acta Diabetol Lat 1985 0.75
194 [Turnover and utilization of glucose and glucose substitutes in human and animals]. Nutr Metab 1975 0.75
195 Comparative study of the metabolism of U- 14 C-fructose, U- 14 C-sorbitol and U- 14 C-xylitol in the normal and in the streptozotocin-diabetic rat. Eur J Clin Invest 1971 0.75
196 Comparison between the metabolism of xylitol, sorbitol, fructose and glucose. Int Z Vitam Ernahrungsforsch Beih 1976 0.75
197 [Metabolism of fructose, essential fructosuria and hereditary fructose intolerance]. Rev Prat 1965 0.75
198 [Diabetic coma]. Internist (Berl) 1965 0.75
199 Insulin-like growth factor I and II in 14 animal species and man as determined by three radioligand assays and two bioassays. Acta Endocrinol (Copenh) 1987 0.75
200 [Deficient dental caries attack in persons with hereditary fructose intolerance]. Helv Med Acta Suppl 1967 0.75
201 [Review on the balance of energy substances with special reference to the metabolism of glucose, fructose, sorbitol and xylitol and their therapeutic utilization]. Int Z Vitam Ernahrungsforsch Beih 1972 0.75
202 Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program. Horm Metab Res Suppl 1979 0.75
203 [Prolactin producing hypophyseal adenoma: diagnosis and therapeutic possibilities]. Schweiz Med Wochenschr 1985 0.75
204 Congenital familial thyroid aplasia. Acta Endocrinol (Copenh) 1981 0.75
205 Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs. Acta Endocrinol (Copenh) 1977 0.75
206 The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S). Acta Endocrinol (Copenh) 1979 0.75
207 [Cushing's syndrome. Case report of 43 patients with Cushing syndrome at the medical university clinic in Zurich in the years 1958-1969]. Schweiz Med Wochenschr 1971 0.75
208 Nonsuppressible insulin-like activity of human serum. Ger Med Mon 1967 0.75
209 [Scientific raisins from 125 years SMW (Swiss Medical Weekly). Diagnostic use of a new adrenostatic agents. 1959]. Schweiz Med Wochenschr 1995 0.75
210 [Persistent disorders of ACTH secretion following surgery of an adrenal cortex adenoma in 3 cases of Cushing's syndrome]. Schweiz Med Wochenschr 1967 0.75
211 NSILA-S, physiologic and pharmacologic significance as an insulinlike hormone and as a growth-promoting hormone. Adv Metab Disord 1975 0.75
212 Protein kinase and cyclic AMP-binding activities in liver and adipose tissue of normal, streptozotocin-diabetic and adrenalectomized rats. FEBS Lett 1973 0.75
213 Small stature and insulin-like growth factors: prolonged treatment of mini-poodles with recombinant human insulin-like growth factor I. Acta Endocrinol (Copenh) 1989 0.75
214 [TSH-producing hypophysis adenoma and secondary hyperthyroidism. Case presentation and literature review]. Schweiz Med Wochenschr 1989 0.75
215 [Feminizing testicular Leydig cell tumor. Case contribution to the differential diagnosis of gynecomastia]. Schweiz Med Wochenschr 1981 0.75
216 [Experimental medicine and diabetes]. Ther Umsch 1967 0.75
217 [NSILA, insulin-like growth factors and somatomedins (author's transl)]. Schweiz Rundsch Med Prax 1979 0.75
218 [Diabeti coma from the present viewpoint]. Med Klin 1966 0.75
219 Nonsuppressible insulin-like activity: biological activity and receptor binding. Isr J Med Sci 1975 0.75
220 The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation. Acta Endocrinol (Copenh) 1977 0.75
221 Insulin-like growth factors in lysosomal storage disease. Eur J Pediatr 1992 0.75
222 Recombinant human insulin-like growth factor I: effects in normal subjects and implications for use in patients. Adv Exp Med Biol 1991 0.75
223 [The degradation of insulin by the isolated rat liver perfused with rat serum and leucine]. Diabetologia 1966 0.75
224 [Progress and developments in insulin therapy]. Schweiz Med Wochenschr 1979 0.75
225 Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2. Metabolism 1983 0.75
226 [Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)]. Ann Endocrinol (Paris) 1981 0.75
227 IGFs/somatomedins: significance for growth. Prog Clin Biol Res 1985 0.75
228 Biological effects of the insulin-like growth factors in vitro: relevance to their actions in vivo. Bull Schweiz Akad Med Wiss 1983 0.75
229 Effect of prolonged optimal blood sugar control by i.v. insulin administration on plasma free fatty acid and glycerol concentrations of insulin-dependent diabetics during exercise. Acta Diabetol Lat 1983 0.75
230 Insulin-like growth factor I and growth hormone in canine starvation. Acta Endocrinol (Copenh) 1985 0.75
231 IGFs: function and clinical importance. J Intern Med 1993 0.75
232 [Infusion solutions with fructose and sorbitol]. Dtsch Med Wochenschr 1983 0.75
233 [Therapy of diabetic coma]. Verh Dtsch Ges Inn Med 1981 0.75
234 [Adjustment of unstable diabetics with a simple insulin infusion program]. Schweiz Med Wochenschr 1978 0.75
235 Non-suppressible insulin-like activity of human serum. VI. Difference between the action of insulin and that of precipitated non-suppressible insulin-like activity on glycogen synthesis of rat adipose tissue and muscle. Biochim Biophys Acta 1971 0.75
236 Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse. Diabetologia 1996 0.75
237 Metabolism and oxidation of U- 14 C-glucose, xylitol, fructose and sorbitol in the fasted and in the streptozotocin-diabetic rat. Diabetologia 1971 0.75
238 [Acromegaly and insulin-like growth factors]. Schweiz Med Wochenschr 1986 0.75
239 [Incidence and clinical manifestation of ACTH-producing pituitary adenoma after bilateral adrenalectomy for Cushing's syndrome (Nelson syndrome)]. Schweiz Med Wochenschr 1981 0.75
240 Purification procedures for NSILA-S. Adv Metab Disord 1975 0.75
241 Transport and metabolism of glucose, insulin sensitivity and lipolysis of epididymal adipose tissue of alloxan-diabetic rats after prolonged incubation in vitro. Diabetologia 1968 0.75
242 [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics]. Schweiz Med Wochenschr 1980 0.75
243 [Serum insulin activity not inhibitable by insulin antibodies]. Dtsch Med Wochenschr 1966 0.75
244 [Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus]. Schweiz Med Wochenschr 1974 0.75
245 [Prevention of diabetic angiopathy?]. Dtsch Med Wochenschr 1971 0.75
246 Differential mood response to natural and synthetic corticosteroids after bilateral adrenalectomy: a case report. J Psychiatr Res 1994 0.75
247 Clinical uses of insulin-like growth factor I. Adv Endocrinol Metab 1995 0.75
248 [Treatment of diabetes mellitus with oral antidiabetics]. Schweiz Med Wochenschr 1976 0.75
249 Recent investigation of the nature of nonsuppressible, acid ethanol soluble insulin-like activity (NSILA-S). Isr J Med Sci 1972 0.75
250 [Malignant hyperthermia: attempt at an early diagnosis by means of determination of creatine phosphokinase (CPK) and its isoenzymes]. Schweiz Med Wochenschr 1976 0.75